Alejandro R Chade

Title: Innovations by Alejandro R Chade in Renal Therapeutics

Introduction

Alejandro R Chade is a prominent inventor based in Brandon, MS (US). He has made significant contributions to the field of renal therapeutics, holding a total of 4 patents. His work focuses on the development of elastin-like polypeptide delivery systems that enhance the treatment of renal disorders.

Latest Patents

Chade's latest patents include a molecular-size elastin-like polypeptide delivery system for therapeutics that modulates intrarenal deposition and bioavailability. This innovative system features a renal cortex targeting elastin-like polypeptide (ELP) and a renal medulla and cortex targeting ELP. The renal cortex targeting ELP consists of up to 95 repeat units with the sequence VPGXG, where X can be any amino acid except proline. Additionally, the renal medulla and cortex targeting ELP includes at least 95 repeat units of the same sequence. The method of treating a renal disorder involves administering an ELP along with a therapeutic drug to a subject in need, where the ELP can contain up to 671 repeat units of the specified sequence.

Career Highlights

Chade is affiliated with the University of Mississippi, where he continues to advance research in the field of renal therapeutics. His innovative approaches have garnered attention and recognition within the scientific community.

Collaborations

Chade has collaborated with notable colleagues, including Gene L Bidwell, III, who have contributed to his research endeavors.

Conclusion

Alejandro R Chade's work in developing elastin-like polypeptide delivery systems represents a significant advancement in the treatment of renal disorders. His contributions continue to impact the field of therapeutics positively.